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Wordcount:  2115 
Abstract:  (285 words) 
Objective: To examine inter-relationships between the local inflammatory response (Klintrup 
and Jass scores) and the systemic inflammatory response (Glasgow Prognostic Score (mGPS)), 
and compare their prognostic value in patients undergoing curative resection for colorectal 
cancer. 
Background:  Both localised peritumoral inflammatory cell infiltrate and the host systemic 
inflammatory response are known to have prognostic value in colorectal cancer.  However, the 
inter-relationships of biochemical and cellular components of the systemic inflammatory response 
and the local inflammatory response are poorly understood. 
Methods:  Retrospective study of 287 patients who underwent surgery between 1997 and 2004.  
Data was collected from routine pre-operative blood tests.  Routine pathology specimens were 
scored according to Jass and Klintrup criteria for peritumoural infiltrate. 
Results:  Increased Dukes stage was associated with less peritumoural infiltrate (Jass criteria 
P<0.001, Klintrup criteria P<0.01).  Increased mGPS was associated with increased circulating 
white cell (P<0.01) and neutrophil (P<0.01) counts and low lymphocyte counts (P<0.01).  
Increased circulating white cell count was associated with increased neutrophil count (P<0.001) 
and low grade peritumoural infiltrate (P<0.05, Klintrup criteria).  Jass and Klintrup criteria for 
peritumoural infiltrate were directly associated (P<0.001).  On univariate survival analysis of 
patients with node negative disease (Dukes A and B), age (P<0.01), mGPS (P<0.01), neutrophil 
count (p<0.05) and Klintrup criteria (P<0.05) and were associated with cancer-specific survival.  
On multivariate survival analysis in node negative disease, the mGPS (HR 2.60, 95% CI 1.27-
5.33, P<0.01) and Klintrup criteria (HR 6.35, 95% CI 1.41-28.53, P<0.05) and were 
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independently associated with cancer specific survival.  
Conclusion:  The present study’s results suggest low peritumoural infiltrate (Klintrup criteria) 
and increased systemic inflammation (mGPS criteria) are linked through the cell mediated 
immune system.  Furthermore, both pathological (Klintrup) and biochemical (mGPS) measures of 
the inflammatory response predict survival following colorectal cancer surgery.   
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Introduction 
Colorectal cancer is the second most common cause of cancer death in Western Europe 
and North America.  Each year in the UK, there are approximately 35,000 new cases and 16,000 
deaths attributable to this disease 1.  Overall survival is poor; even in those who undergo resection 
with curative intent, only half survive five years 2.  
It has long been recognised that disease progression in cancer patients is not solely 
determined by the local characteristics of the tumour but also by the systemic host response. 
Indeed, there is increasing evidence that both local and systemic inflammatory responses play an 
important role in the progression of a variety of common solid tumours 3 4. 
In terms of the localised tumour, there is good evidence that in patients with colorectal 
cancer, the presence of a pronounced lymphocytic infiltrate around the infiltrating tumour, on 
simple H&E staining of sections, is associated with improved survival 5 6 7.  Futhermore, Galon 
and co-workers have provided further persuasive evidence that the type, density and location of 
immune cells in colorectal tumours may provide prognostic information superior to that of 
tumour staging 8. 
Klintrup and co-workers have simplified the subjective measurement of the tumour 
inflammatory infiltrate by including all white blood cell types and classifying the inflammatory 
infiltrate as either low or high grade 9.  They showed that a high grade inflammatory infiltrate was 
associated with improved survival in patients undergoing potentially curative resection of node 
negative colorectal cancer. 
In terms of systemic inflammation, there is now good evidence that the presence of a 
systemic inflammatory response, as evidenced by a simple objective score (Glasgow Prognostic 
Score, GPS), based on elevated circulating concentrations of C-reactive protein and 
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hypoalbuminaemia, is independently associated with poor outcome in patients with colorectal 
cancer 10 11 12. 
The aim of the present study was to examine the inter-relationships between these local 
subjective pathological (Jass and Klintrup criteria) and systemic objective biochemical (GPS 
criteria) inflammatory scores and to compare their prognostic value in patients undergoing 
potentially curative resection for colorectal cancer.     
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Materials and methods 
 Patients with histologically proven colorectal cancer who, on the basis of laparotomy 
findings and pre-operative abdominal computed tomography, were considered to have undergone 
potentially curative resection between January 1997 and June 2004 in a single surgical unit at 
Glasgow Royal Infirmary, were included in the study.  Exclusion criteria were (i) emergency 
presentation, (ii) clinical evidence of infection, (iii) presence of a chronic inflammatory condition, 
(iv) pre-operative radiotherapy or (v) death within 30 days of surgery.  The tumours were staged 
using conventional Dukes classification 13.  
The routine haematoxylin and eosin slides were retrieved from the pathology archives.  A 
minimum of three slides from the deepest area of tumour invasion were selected and scored 
according to both Jass 5 and Klintrup 9 criteria.  Jass scoring of slides were carried out as 
described previously 5 14.  Briefly, the term “peritumoural lymphocytic infiltrate” was applied to 
the stromal response at the tumours’ invasive edge.  Specific features of this response are: the 
presence of a loose connective tissue lamina or cap at the deepest point of tumour penetration; a 
heavy infiltration of neutrophils, macrophages, eosinophils lymphocytes and plasma cells 
between glands; and most importantly the presence of loose connective tissue stroma.  The 
tumours were scored on a 2-point scale as either peritumoural infiltrate present or absent.  
Klintrup scoring of slides were carried out as described previously 9.  Briefly, tumours 
were scored according to a 4 point score.  Scores were allocated based on appearances at the 
deepest area of tumour invasion.  A score of 0 was given where there was no increase in 
inflammatory cells at the deepest point of the tumours’ invasive margin; 1 denoting a mild and 
patchy increase in inflammatory cells; 2 denoting a prominent inflammatory reaction forming a 
band at the invasive margin with some evidence of destruction of cancer cell islands; 3 denoting a 
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florid cup-like inflammatory infiltrate at the invasive edge with frequent destruction of cancer cell 
islands.  These scores were then subsequently classified as low grade (scores 0 and 1) and high 
grade (scores 2 and 3) (Figures 1 and 2). 
A total of 162 tumour specimens were scored independently by 2 observers (CSDR and 
JMS), who were blinded to patient outcome, to confirm consistency of scoring.  The inter-
observers intraclass correlation coefficients (ICCC) were as follow; Jass  =0.71 and Klintrup 
=0.81 (ICCC values ≥ 0.6 were considered acceptable).  CSDR scored all slides (n=287) and 
these data were used in the analysis.   
Blood samples were taken for routine laboratory measurements of albumin, C-reactive 
protein and differential white cell count measurement prior to surgery.  The coefficient of 
variation for these methods, over the range of measurement, was less than 5% as established by 
routine quality control procedures.   
The GPS was constructed as previously described 15.  Briefly, patients with both an 
elevated C-reactive protein (>10mg/l) and hypoalbuminaemia (<35g/l) were allocated a score of 
2.  Patients in whom only one of these biochemical abnormalities was present were allocated a 
score of 1.  Patients in whom neither of these abnormalities was present were allocated a score of 
0.  The GPS has recently been modified based on evidence that hypoalbuminaemia, in patients 
with colorectal cancer without an elevated C-reactive protein concentration, had no significant 
association with cancer specific survival.  Therefore, patients with an elevated C-reactive protein 
were assigned a modified GPS score (mGPS) of 1 or 2 depending on the presence of 
hypoalbuminaemia 10.  
The study was approved by the Research Ethics Committee, Royal Infirmary, Glasgow. 
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Grouping of the variables was carried out using standard thresholds.  Inter-relationships 
between variables were assessed using contingency table analysis with the chi-squared test for 
trend as appropriate.  Univariate and multivariate survival analysis and calculation of hazard 
ratios (HR) were performed using Cox’s proportional-hazards model.  A stepwise backward 
procedure was used to derive a final model of the variables that had a significant independent 
relationship with survival.  To remove a variable from the model, the corresponding P-value had 
to be greater than 0.05.  Deaths from colorectal cancer up to September 2007 were included in the 
analysis.  Statistical analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA). 
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Results 
Two hundred and eighty seven patients undergoing potentially curative resection for 
colorectal cancer were studied.  The majority of patients were 65 or older (68%), were male 
(54%), had colonic tumours (61%) and Dukes A/B disease (59%).  Median number of lymph 
nodes sampled was 14 (range 1-41) for Dukes B tumours and 13 (range 3-34) for Dukes C 
tumours.  One hundred and sixteen (40%) patients had an elevated C-reactive protein 
concentration (>10 mg/l), and 50 (17%) patients had hypoalbuminaemia (<35g/l).  Of the 50 
patients with hypoalbuminaemia, 34 (68%) had an elevated C-reactive protein.  The majority of 
tumours had no evidence of peritumoural inflammatory infiltrate using either Jass (76%) or 
Klintrup (65%) criteria.  Sixty-seven (23%) patients received adjuvant therapy.    
The inter-relationships between inflammation-based pathological and biochemical criteria 
are shown in Table 1.  Old age was associated with a greater proportion of females (P<0.01), 
colonic tumours (P<0.01) and elevated mGPS (P<0.01).  Increased Dukes stage was associated 
with less peritumoural infiltrate (Jass criteria P<0.001, Klintrup criteria P<0.01). Increased mGPS 
was associated with increased circulating white cell (P<0.01) and neutrophil (P<0.01) counts and 
low lymphocyte counts (P<0.01).  Increased circulating white cell count was associated with 
increased neutrophil count (P<.001) and low grade peritumoural infiltrate (P<0.05, Klintrup 
criteria).  Jass and Klintrup criteria for peritumoural infiltrate were directly associated (P<0.001).  
The minimum follow-up was 34 months; the median follow-up of the survivors was 71 
months.  No patients were lost to follow up.  During this period, 67 patients died of their cancer 
and a further 49 patients died of intercurrent disease.  The relationship between clinical, 
pathological and biochemical characteristics and cancer specific survival in patients undergoing 
potentially curative resection for colorectal cancer is shown in Table 2. 
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On univariate survival analysis, age (P<0.001), Dukes stage (P<0.001), mGPS (P<0.001), 
total white cell count (P<0.01), neutrophil count (P<0.01) and a low grade or absent peritumoural 
inflammatory cell infiltrate assessed by either Jass criteria (P<0.01) or Klintrup criteria (P<0.001) 
were associated significantly with cancer-specific survival.  On multivariate survival analysis the 
significant individual variables of age (HR 1.60, 95% CI 1.06-2.41, P<0.05), Dukes stage (HR 
2.20, 95% CI 1.17-4.13, P<0.05), the mGPS (HR 2.65, 95% CI 1.66-4.25, p<0.001) and Klintrup 
criteria (HR 3.70, 95% CI 0.18-3.05, P<0.05) were independently associated with cancer specific 
survival (Table 2).   
On univariate survival analysis of patients with node negative disease (Dukes A and B), 
age (P<0.01), mGPS (P<0.01), neutrophil count (p<0.05) and Klintrup criteria (P<0.05) and were 
associated with cancer-specific survival.  On multivariate survival analysis, the mGPS (HR 2.60, 
95% CI 1.27-5.33, P<0.01) and Klintrup criteria (HR 6.35, 95% CI 1.41-28.53, P<0.05) and were 
independently associated with cancer specific survival.   
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Discussion 
The present study, to our knowledge, shows for the first time the inter-relationships 
between the preoperative systemic inflammatory response (GPS criteria), peritumoural 
inflammatory infiltrate (Jass and Klintrup criteria) and cancer specific survival in patients 
undergoing potentially curative resection for colorectal cancer.  In the present study, a low grade 
peritumoural infiltrate, measured by the Klintrup criteria, was associated with increased Dukes 
stage and increased circulating total white cell count and neutrophil count.  Furthermore, 
peritumoural infiltrate (Klintrup criteria) was independently associated with cancer specific 
survival.  
The results of the present study are consistent with those reported by Klintrup and co-
workers 9.  In a study of 374 patients (229 with node-negative disease) who underwent surgery 
between 1986 and 1996, a significant relationship was observed between low grade inflammatory 
infiltrate at the invasive margin and poor survival.  In the same study, in addition to a grading all 
white cell counts at the invasive margin, increased neutrophils, lymphocytes and macrophages 
were all correlated with an improved 5 year survival.   
In contrast, the systemic inflammatory response, measured by mGPS criteria, was not 
associated with Dukes stage nor peritumoural infiltrate (Jass or Klintrup criteria), but was 
associated with increased circulating total white cell count, increased neutrophil count and 
decreased circulating lymphocyte count.  The mGPS was also independently associated with 
cancer specific survival in patients undergoing potentially curative resection for colorectal cancer.  
Taken together the results of the present study suggest that both low peritumoural infiltrate 
(Klintrup criteria) and increased systemic inflammation (mGPS criteria) are linked through the 
cell mediated immune system, both acquired (lymphocytes) and innate immune (neutrophils) 
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cells.  Furthermore, both pathological (Klintrup) and biochemical (mGPS) measures of the 
inflammatory response predict cancer specific survival following potentially curative resection for 
colorectal cancer. 
Although colon and rectal tumours may be considered as separate entities there was, in the 
present study no significant association in colorectal cancer survival.  In contrast, peritumoural 
infiltrate as measured by Jass and Klintrup criteria were associated with significant differences in 
colorectal cancer survival.  Therefore, in the present study, we have not considered colon and 
rectum tumours separately.  Also, there are a number of factors which might result in the presence 
of a pre-operative systemic inflammatory response as evidenced by the mGPS (i.e. C-reactive 
protein and albumin).  These include emergency presentation 16, and clinical evidence of infection 
and other chronic inflammatory conditions.  In the present study, patients with such factors were 
excluded from the analysis to obviate confounding results.   
The basis of the relationship between the systemic inflammatory response (mGPS) and 
poorer cancer specific survival is not clear and likely to be complex.  However, it is clear that 
systemic inflammatory markers, such as C-reactive protein, play a pivotal role in the tumour–host 
relationship, its elevation reflecting compromised cell-mediated immunity as it is associated with 
lymphocytopenia and impaired T lymphocytic response within the tumour 17 18.  In addition, 
elevated C-reactive protein and hypoalbuminaemia have also been shown to be associated with 
upregulation of components of innate immune system, including complement and macrophage 
function 17 19.  As part of the systemic inflammatory response, there is a release of pro-
inflammatory cytokines and growth factors which may promote and maintain tumour growth 20 21.  
Taken together, the apparent inverse relationship between markers of the systemic inflammatory 
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response and the local inflammatory response are likely to reflect imbalances in the innate and 
adaptive immune systems compromising effective host-tumour immune responses. 
The results of the present study are consistent with previous studies in that where a high 
grade local inflammatory response exists, a variety of innate and adaptive immune cells are 
associated with long term survival 5 6 7 8 9.  Also, the results of the present study suggest that the 
systemic inflammatory response is associated with changes in the type, density and location of 
immune cells in colorectal tumours type.  Further detailed investigation of this relationship may 
result in a better understanding of the loss immune control in patients with primary operable 
colorectal cancer.   
In the present study although both pathological (Klintrup criteria) and biochemical 
(mGPS) measures of the inflammatory response had independent prognostic value it is more 
likely that the mGPS will be adopted for the routine clinical assessment of the inflammatory 
response alongside tumour staging because the mGPS is simple, objective, internationally well 
standardised and can be measured pre-operatively.  
The systemic inflammatory response is also recognised to be a precursor to progressive 
involuntary loss of weight and lean tissue, both of which are key factors in determining the 
survival of the cancer patient 22.  Moreover, the mGPS, can be used, in addition to traditional risk 
factors, to stratify colorectal cancer patients into specific follow-up 11 12 and perhaps treatment 
regimes 23. 
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Figure 1:  Low grade or absent inflammatory cell infiltrate at the tumour’s invasive margin 
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Figure 2: High Grade inflammatory cell infiltrate at the tumour’s invasive margin. 
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Table 1:  Inter-relationships between the inflammation based pathological and biochemical criteria in patients undergoing potentially curative 
resection for colorectal cancer (n=287). 
 
 Sex  
(F/ M) 
Site 
(C/ R) 
Dukes 
(A/ B/ C) 
mGPS 
(0-2) 
White cell 
count 
(<8.5/8.5-
11/>11) 
Neutrophils 
(<7.5/ >7.5) 
Lymphocytes 
(<1/1-3/>3) 
Jass criteria 
(Yes/ No) 
Klintrup criteria 
(Yes/ No) 
Age 
(<65/ 65-74/ >75yrs) 
 
0.008 
 
0.004 
 
0.724 
 
0.004 
 
0.484 
 
0.966 
 
0.298 
 
0.329 
 
0.983 
Sex 
(Female/ Male) 
  
0.124 
 
0.628 
 
0.205 
 
0.401 
 
0.513 
 
0.149 
 
0.834 
 
0.641 
Tumour site 
(Colon/ Rectum) 
   
0.813 
 
0.082 
 
0.303 
 
0.438 
 
0.070 
 
0.448 
 
0.443 
Dukes stage 
(A/ B/ C) 
    
0.871 
 
0.197 
 
0.271 
 
0.960 
 
<0.001 
 
0.001 
mGPS 
(0-2) 
     
0.003 
 
0.001 
 
0.005 
 
0.128 
 
0.626 
White Cell Count 
(<8.5/ 8.5-11/ 
>11x109/L) 
Neutrophils 
(<7.5/ >7.5x109/L) 
Lymphocytes  
(<1/ 1-3/ >3 x109/L)  
    
 
 
 
 
 
  
<0.001 
 
 
 
 
 
0.135 
 
0.684 
 
0.164 
 
0.241 
 
0.173 
 
0.012 
 
0.067 
 
0.412 
Peritumoural Infiltrate  
(Jass criteria) 
Cap-like (Yes/ No) 
    
 
     
<0.001 
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Table 2.  The relationship between clinical, pathological and biochemical characteristics and cancer specific survival in patients undergoing 
potentially curative resection for colorectal cancer:  Univariate and multivariate analysis.  
 
 
Patients 
n=287 (%) 
Univariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Multivariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Age  <65 years 
        65-74years 
        >75years 
91 (32) 
93 (32) 
103 (36) 
 
 
1.81 (1.32-2.48) 
 
 
<0.001 
 
 
1.60 (1.06-2.41) 
 
 
0.027 
Sex  Female 
        Male 
133 (46) 
154 (54) 
 
0.75 (0.47-1.22) 
 
0.250 
  
 
Tumour site  Colon 
                     Rectum 
174 (61) 
113 (39) 
 
0.87 (0.53-1.43) 
 
0.580 
 
 
 
Lymph nodes sampled     >12 
                                       <12 
172 (60) 
115 (40) 
 
1.36 (0.84-2.20) 
 
0.212 
  
Dukes Stage  A 
                      B 
                      C 
22 (8) 
146 (51) 
119 (41) 
 
 
2.44 (1.56-3.83) 
 
 
<0.001 
 
 
2.20 (1.17-4.13) 
 
 
0.014 
mGlasgow Prognostic Score                                
                                       0 
                                       1 
                                       2 
 
171 (60) 
82 (28) 
34 (12) 
 
 
 
2.17 (1.61-2.92) 
 
 
 
<0.001 
 
 
 
2.65 (1.66-4.25) 
 
 
 
<0.001 
Adjuvant therapy   no 
                               yes 
220 (77) 
67 (23) 
 
1.24 (0.72-2.12) 
 
0.443 
 
 
 
 
White Cell Count  
                     <8.5 x109/L 
                      8.5-11 x109/L 
                      >11 x109/L  
Neutrophils  <7.5 x109/L 
                      >7.5 x109/L 
Lymphocytes <1 x109/L 
                      1-3 x109/L 
                      >3 x109/L 
 
117 (62) 
50 (26) 
23 (12) 
158 (83) 
32 (17) 
21 (11) 
161 (85) 
8 (4) 
 
 
 
1.76 (1.15-2.69) 
 
2.80 (1.38-5.69) 
 
 
1.32 (0.55-3.19) 
 
 
 
0.009 
 
0.004 
 
 
0.553 
 
 
 
1.04 (0.52-2.08) 
 
1.40 (0.43-4.59) 
 
 
 
0.905 
 
0.582 
Peritumoural Infiltrate 
  Jass criteria 
    Cap-like    yes 
    Cap-like    no 
 
 
63 (24) 
219 (76) 
 
 
 
2.83 (1.29-6.20) 
 
 
 
0.009 
 
 
 
0.73 (0.18-3.05) 
 
 
 
0.670 
  Klintrup criteria 
    High grade inflammation 
    Low grade inflammation 
 
99 (35) 
188 (65) 
 
 
4.43 (2.12-9.27) 
 
 
<0.001 
 
 
3.701 (1.11-12.33) 
 
 
0.033 
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Table 3. The relationship between clinical, pathological and biochemical characteristics and cancer specific survival in patients undergoing 
potentially curative resection for node-negative (Dukes A and B) colorectal cancer:  Univariate and multivariate analysis.  
 
 
Patients 
n=169(%) 
Univariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Multivariate Analysis 
Hazard Ratio (95% CI) 
 
P-value 
Age  <65 years 
        65-74years 
        >75years 
49 (29) 
58 (34) 
62 (37) 
 
 
2.29 (1.32-3.99) 
 
 
0.003 
 
 
1.99 (0.99-4.01) 
 
 
0.055 
Sex  Female 
        Male 
75 (44) 
94 (56) 
 
0.47 (0.35-1.62) 
 
0.467 
 
 
 
 
Tumour site  Colon 
                     Rectum 
107 (63) 
62 (37) 
 
0.91 (0.40-2.03) 
 
0.808 
 
 
 
 
Lymph nodes sampled     >12 
                                       <12 
101 (60) 
66 (40) 
 
1.98 (0.92-4.29) 
 
0.082 
  
Dukes Stage       A 
                          B 
22 (13) 
147 (87) 
 
1.48 (0.35-6.32) 
 
0.597 
  
mGlasgow Prognostic Score                                  
                                       0 
                                       1 
                                       2 
 
98 (58) 
48 (28) 
23 (14) 
 
 
 
2.09 (1.31-3.34) 
 
 
 
0.002 
 
 
 
2.60 (1.27-5.33) 
 
 
 
0.009 
Adjuvant therapy  no 
                              yes 
155 (92) 
14 (8) 
 
1.06 (0.25-4.50) 
 
0.935 
 
 
 
 
White Cell Count  
                     <8.5 x109/L 
                      8.5-11 x109/L 
                      >11 x109/L  
Neutrophils  <7.5 x109/L 
                      >7.5 x109/L 
Lymphocytes <1 x109/L 
                      1-3 x109/L 
                      >3 x109/L 
 
69 (63) 
27 (25) 
13 (12) 
91 (83) 
18 (17) 
13 (12) 
93 (85) 
3 (3) 
 
 
 
1.83 (0.95-3.52) 
 
3.32 (1.13-9.76) 
 
 
1.61 (0.44-5.88) 
 
 
 
0.070 
 
0.029 
 
 
0.470 
 
 
 
0.87 (0.24-3.07) 
 
3.55 (0.36-35.48) 
 
 
 
0.822 
 
0.281 
Peritumoural Infiltrate     
  Jass criteria   
    Cap-like    yes 
    Cap-like   no 
 
 
46 (27) 
123 (73) 
 
 
 
2.58 (0.59-11.34) 
 
 
 
0.208 
 
 
 
 
 
 
 
 
  Klintrup criteria 
    High grade inflammation 
    Low grade inflammation 
 
68 (40) 
101 (60) 
 
 
3.99 (1.38-11.59) 
 
 
0.011 
 
 
6.35 (1.41-28.53) 
 
 
0.016 
 
